Search results for "KIDNEY TRANSPLANT"

showing 10 items of 165 documents

Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the imme…

2018

Abstract Objective Previous studies on monitoring of post-transplant cytomegalovirus (CMV)-specific cell-mediated immunity (CMI) are limited by single-centre designs and disparate risk categories. We aimed to assess the clinical value of a regular monitoring strategy in a large multicentre cohort of intermediate-risk kidney transplant (KT) recipients. Methods We recruited 124 CMV-seropositive KT recipients with no T-cell-depleting induction pre-emptively managed at four Spanish institutions. CMV-specific interferon-γ-producing CD4+ and CD8+ T cells were counted through the first post-transplant year by intracellular cytokine staining after stimulation with pp65 and immediate early-1 peptide…

Male0301 basic medicineMicrobiology (medical)medicine.medical_specialtyT-Lymphocytesmedicine.medical_treatment030106 microbiologyCongenital cytomegalovirus infectionCytomegalovirusAsymptomaticInterferon-gamma03 medical and health sciences0302 clinical medicineMonitoring ImmunologicPredictive Value of TestsRisk FactorsImmune monitoring intracellular cytokine stainingInternal medicinemedicineHumansCumulative incidenceLymphocyte Count030212 general & internal medicineKidney transplantationAgedImmunity Cellularbusiness.industryIncidence (epidemiology)virus diseasesImmunosuppressionGeneral MedicineMiddle Agedmedicine.diseaseKidney TransplantationTransplant RecipientsTransplantationInfectious DiseasesCytomegalovirus InfectionsCohortCell-mediated immunityFemalemedicine.symptombusinessClinical Microbiology and Infection
researchProduct

Association of time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected bacteria of patients af…

2017

Background Aim of this study was to investigate the association of the time under immunosuppression and different immunosuppressive medication on periodontal parameters and selected periodontal pathogenic bacteria of immunosuppressed patients after solid organ transplantation (SOT). Material and Methods 169 Patients after SOT (lung, liver or kidney) were included and divided into subgroups according their time under (0-1, 1-3, 3-6, 6-10 and >10 years) and form of immunosuppression (Tacrolimus, Cyclosporine, Mycophenolate, Glucocorticoids, Sirolimus and monotherapy vs. combination). Periodontal probing depth (PPD) and clinical attachment loss (CAL) were assessed. Periodontal disease severity…

Male0301 basic medicinemedicine.medical_specialtyTime FactorsCombination therapymedicine.medical_treatmentMedizinGastroenterology03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicinePeriodontal Attachment LossmedicineHumansTannerella forsythiaPeriodontal ProbingGeneral DentistryKidney transplantationBacteriabiologybusiness.industryResearchImmunosuppression030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in Dentistrymedicine.diseasebiology.organism_classificationKidney TransplantationTacrolimusLiver Transplantationstomatognathic diseasesCross-Sectional Studies030104 developmental biologyOtorhinolaryngologyClinical attachment lossUNESCO::CIENCIAS MÉDICASFemaleSurgeryPeriodontal IndexFusobacterium nucleatumbusinessImmunosuppressive AgentsLung Transplantation
researchProduct

Anti-HLA alloantibodies of the IgA isotype in re-transplant candidates part II: Correlation with graft survival

2017

We reported previously on the widespread occurrence of anti-HLA alloantibodies of the IgA isotype (anti-HLA IgA) in the sera of solid-organ re-transplantation (re-tx) candidates (Arnold et al., ). Specifically focussing on kidney re-tx patients, we now extended our earlier findings by examining the impact of the presence and donor specificity of anti-HLA IgA on graft survival. We observed frequent concurrence of anti-HLA IgA and anti-HLA IgG in 27% of our multicenter collective of 694 kidney re-tx patients. This subgroup displayed significantly reduced graft survival as evidenced by the median time to first dialysis after transplantation (TTD 77 months) compared to patients carrying either …

Male0301 basic medicinemedicine.medical_treatmentMedizinHistocompatibility Testing030230 surgery0302 clinical medicineAntibody SpecificityHLA AntigensIsoantibodiesMedicineChildGenetics (clinical)Aged 80 and overKidneybiologyGraft SurvivalGeneral MedicineMiddle AgedPrognosisIsotypemedicine.anatomical_structureChild PreschoolRetreatmentFemaleAntibodyAdultAdolescentImmunologyHuman leukocyte antigenYoung Adult03 medical and health sciencesGeneticsHumansMolecular BiologyAllelesDialysisAgedbusiness.industryOrgan TransplantationKidney TransplantationTransplant RecipientsImmunoglobulin ATransplantation030104 developmental biologyImmunoglobulin GImmunologybiology.proteinGraft survivalbusinessInternational Journal of Immunogenetics
researchProduct

Psychosocial adjustment and quality of life after renal transplantation in early childhood.

2004

Psychosocial adjustment and quality of life has been reported good in children after a successful renal transplantation (Tx). There are, however, few reports of using standardized methods in evaluating these issues, particularly in small children. We investigated the psychosocial adjustment in 32 children at school age (mean 9.6 +/- 1.6), who had received a renal Tx under the age of 5 yr, using the Achenbach Child Behavior Checklist with data collected from both parents (CBCL) and teachers (CBCL-TRF). Health-related quality of life (HRQOL) was assessed by interviewing the children using a 17-dimensional (17D) health-related measure and compared to HRQOL of 244 normal school children. The ef…

MaleParentsPediatricsmedicine.medical_specialty030232 urology & nephrologyPsychological interventionChild BehaviorCBCL030230 surgeryStatistics Nonparametric03 medical and health sciences0302 clinical medicineSex FactorsQuality of lifemedicineHumansChild Behavior ChecklistChildSocial BehaviorTransplantationbusiness.industryTeachingAge FactorsSocial Supportmedicine.diseaseComorbidityKidney TransplantationSelf Concept3. Good healthTransplantationEl NiñoAttention Deficit and Disruptive Behavior DisordersPediatrics Perinatology and Child HealthQuality of LifeFemalebusinessPsychosocialAttitude to HealthSocial AdjustmentPediatric transplantation
researchProduct

Late, giant brachial artery aneurysm following hemodialysis fistula ligation in a renal transplant patient: case report and literature review.

2012

Brachial artery aneurysm (BAA) following long-standing arteriovenous fistula ligation after renal transplantation is uncommon. Herein, we describe the case of a 64-year-old man who developed a giant symptomatic BAA 21 years after ligation of the fistula. He was submitted to surgical excision of the aneurysm followed by interposition prosthetic graft.

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyBrachial ArteryFistulamedicine.medical_treatmentArteriovenous fistulaSettore MED/22 - Chirurgia VascolareArteriovenous Shunt SurgicalAneurysmRenal Dialysismedicine.arterymedicineHumanscardiovascular diseasesBrachial arteryLigationbusiness.industryBrachial artery aneurysm Renal transplantation Dialysis Surgical bypassGeneral MedicineMiddle Agedmedicine.diseaseAneurysmKidney TransplantationSurgeryTransplantationCardiothoracic surgerycardiovascular systemSurgeryRadiologyHemodialysisCardiology and Cardiovascular MedicineLigationbusiness
researchProduct

Impact of Sarcopenia on Clinical Outcomes of Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Cohort Study

2021

International audience; Background: The impact of sarcopenia in patients undergoing simultaneous liver and kidney transplantation (SLKT) has not been fully delineated. The aim of this single-centre-cohort-study was to evaluate the impact of sarcopenia on the clinical outcomes. Methods: Between 2003 and 2018, 79 patients underwent SLKT. Sarcopenia was assessed via the total psoas muscle area (TPA) at the level of the 3rd. lumbar vertebra. Sarcopenia threshold was TPA < 1460 mm2 (women) and <1560 mm2 (men). We identified post-operative biliary, vascular and digestive complications. Survival analysis was performed by the Kaplan Meier method (log-rank test). Results: We included 43/79 SLK…

MaleSarcopeniamedicine.medical_specialtymedicine.medical_treatment[SDV]Life Sciences [q-bio]Liver transplantationCohort Studies03 medical and health sciences0302 clinical medicineRenal DialysisInternal medicinemedicineHumansKidney transplantationDialysisHepatologybusiness.industryGastroenterologyPostoperative complicationMiddle Agedmedicine.diseaseKidney TransplantationLiver TransplantationTransplantationTreatment Outcome030220 oncology & carcinogenesisSarcopeniaCohortFemale030211 gastroenterology & hepatologybusinessCohort study
researchProduct

Determinants of enhanced thromboxane biosynthesis in renal transplantation

2001

Determinants of enhanced thromboxane biosynthesis in renal transplantation.BackgroundDespite great improvement in patient and graft survival, the long-term morbidity and mortality in renal transplant recipients (RTRs) are still significant, with a high incidence of cardiovascular disease-related deaths.MethodsWe investigated thromboxane (TXA2) biosynthesis and endothelial and coagulative activation in 65 patients who received a renal transplant.ResultsThe rate of TXA2 biosynthesis (urinary 11-dehydro-TXB2 excretion largely reflects platelet TXA2 production in vivo) was significantly (P < 0.0001) higher in RTRs than in healthy subjects. Plasma von Willebrand factor (vWF) and thrombin-antithr…

MaleSettore MED/09 - Medicina InternaThromboxanegraft survivalThromboxanevon Willebrand factorImmunosuppressive AgentThromboxane A2chemistry.chemical_compoundReference ValuesRenal Dialysicardiovascular diseaseReference ValuePlateletPostoperative PeriodKidney transplantationKidneyimmunosuppressionnephrotoxicityThromboxanesMiddle AgedCholesterolmedicine.anatomical_structureNephrologyCyclosporineFemaleCardiovascular disease; Graft survival; Immunosuppression; Kidney transplantation; Nephrotoxicity; Von Willebrand factor; Adult; Antithrombin III; Cardiovascular Diseases; Cholesterol; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Peptide Hydrolases; Postoperative Period; Reference Values; Renal Dialysis; Thromboxanes; von Willebrand Factor; Kidney Transplantation; NephrologyImmunosuppressive AgentsHumancirculatory and respiratory physiologyAdultmedicine.medical_specialtyAntithrombin IIIUrologykidney transplantationFollow-Up StudieEndothelial activationRenal DialysismedicineHumansPlatelet activationcardiovascular disease; cardiovascular diseases; graft survival; immunosuppression; kidney transplantation; nephrotoxicity; von willebrand factorbusiness.industrymedicine.diseasecardiovascular diseasesTransplantationPeptide HydrolasechemistryImmunologybusinessFollow-Up StudiesPeptide HydrolasesKidney International
researchProduct

Risk factors for non-melanoma skin cancer in kidney transplant patients in a Spanish population in the Mediterranean region.

2013

Non-melanoma skin cancer (NMSC) is the most frequent malignancy in organ transplant recipients. The aetiology of NMSC after transplant is multifactorial. The aim of this study was to determine the clinical and environmental factors involved in the development of NMSC in a Spanish kidney transplant population from the Mediterranean region. A total of 289 patients who had received a kidney transplant during the period January 1996 to December 2010 were included in the study. Both prospective and retrospective data were used. All patients underwent a structured interview and a complete examination of the skin. After a median follow-up of 72 months (range 12-180 months), 73 of the 289 patients …

MaleSkin NeoplasmsTime FactorsBiopsyKaplan-Meier EstimateOrgan transplantationRisk FactorsSurveys and QuestionnairesCumulative incidenceProspective StudiesCàncerProspective cohort studyeducation.field_of_studyMediterranean RegionIncidence (epidemiology)IncidenceAge FactorsPellGeneral MedicineMiddle AgedDermatologiaCarcinoma Squamous CellSunlightFemaleImmunosuppressive AgentsAdultmedicine.medical_specialtyAdolescentPopulationDermatologyRisk AssessmentNefrologiaYoung AdultInternal medicineOccupational ExposuremedicineHumanseducationAgedProportional Hazards ModelsRetrospective StudiesRonyonsbusiness.industryRetrospective cohort studymedicine.diseaseKidney TransplantationSurgeryTransplantationCarcinoma Basal CellSpainMultivariate AnalysisSkin cancerbusinessPrecancerous ConditionsActa dermato-venereologica
researchProduct

Anastomotic Pseudoaneurysm Complicating Renal Transplantation: Treatment Options

2010

Introduction: Anastomotic pseudoaneurysm following renal transplantation is uncommon. Indications for repair, treatment options and outcomes remain controversial. Report: We present 6 renal transplant recipients with large anastomotic pseudoaneurysms. Five of the patients underwent open repair while one had a stent-grafting and delayed transplant nephrectomy for a ruptured pseudoaneurysm. A transplant nephrectomy was needed in all cases but one. Arterial reconstruction enabled limb salvage in all cases. One patient died of sepsis postoperatively. No patient presented late infection, failure of vascular reconstruction, nor pseudoaneurysm recurrence. Conclusions: Surgical excision of anastomo…

MaleTime FactorsSettore MED/22 - Chirurgia VascolareNephrectomyTransplant nephrectomyPseudoaneurysmRenal ArteryStentTransplantation HomologouMedicine(all)Open repairAnastomosis SurgicalTreatment optionsMiddle AgedBlood Vessel ProsthesiTreatment Outcomesurgical procedures operativecardiovascular systemOpen repairFemaleStentsRadiologyCardiology and Cardiovascular MedicineAneurysm FalseHumanAdultReoperationmedicine.medical_specialtyTime FactorAnastomosisIliac ArterySepsisBlood Vessel Prosthesis ImplantationAneurysmEndovascular repairmedicineHumansTransplantation HomologousStent-graftcardiovascular diseasesAgedbusiness.industryRenal transplantationmedicine.diseaseKidney TransplantationSurgeryBlood Vessel ProsthesisTransplantationSurgerybusinessTomography X-Ray ComputedAneurysm InfectedEuropean Journal of Vascular and Endovascular Surgery
researchProduct

Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry.

2022

RATIONALE AND OBJECTIVE: There is a dearth of data characterizing patients requiring kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) and their clinical outcomes. The aim of this study was to describe trends in incidence and prevalence of KRT among these patients as well as to compare their outcomes to patients treated with KRT for diseases other than SLE.STUDY DESIGN: Retrospective cohort study based on kidney registry data.SETTING &amp; PARTICIPANTS: Patients recorded in 14 registries of patients receiving kidney replacement therapy that provided data to the European Renal Association (ERA) Registry between 1992 and 2016.PREDICTOR: SLE as cause…

Malekidney diseasemedicine.medical_treatmentMAINTENANCE DIALYSIS030232 urology & nephrologyLupus nephritislupus nephritis (LN)0302 clinical medicineLupus Erythematosus Systemickidney replacement therapy (KRT)RegistriesRenal InsufficiencyKidney transplantationRISKeducation.field_of_studyKidneyregistry studyIncidence (epidemiology)IncidenceSTAGE RENAL-DISEASELupus Nephritis3. Good healthEuropeRenal Replacement Therapymedicine.anatomical_structureNephrologySURVIVALFemalemedicine.medical_specialtyprevalencePopulationkidney transplantationUNITED-STATESsurvival03 medical and health sciencesAFRICAN-AMERICAN PATIENTSInternal medicinemedicineHumansESRDeducationNEPHRITISDialysisRetrospective Studies030203 arthritis & rheumatologyProportional hazards modelbusiness.industryTRANSPLANTATIONMORTALITYRetrospective cohort studymedicine.diseasekidney failureend-stage renal disease (ESRD)3121 General medicine internal medicine and other clinical medicineSystemic lupus erythematosus (SLE)Kidney Failure ChronicprognosisbusinessAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
researchProduct